Stop EpiPen Profiteering: Drop the price of this lifesaving medicine NOW! Target: Heather Bresch, CEO, Mylan Pharmaceuticals Sign the petition Update: Mylan has now responded to consumer outrage with a claim that they’re cutting EpiPen's price in half. But this is pure corporate spin. The price cuts only apply to some underinsured consumers, who will get a $300 savings card. Everyone else, including anyone receiving Medicare or Medicaid, continues to pay the outrageous $600 price tag.